HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells.
Xia L, Wen L, Qin Y, Dobson HE, Zhang T, Comer FI, Hinrichs MJane, Oberst MD, Coats SR, Chang AE, et al. HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells. Cell Chem Biol. 2021.